In rats with renal disease, low-protein diets slow the decline in rena
l function, histologic damage, and mortality. Low-protein (and phospho
rus) diets can also ameliorate uremic symptoms, secondary hyperparathy
roidism, and metabolic acidosis in patients with chronic renal failure
. Albeit controversial, evidence also suggests that dietary protein re
striction can slow the rate of progression of renal failure and the ti
me until end-stage renal failure. These dietary regimens appear to be
safe and patients with chronic renal failure are able to activate norm
al compensatory mechanisms designed to conserve lean body mass when di
etary protein intake is restricted. When low-protein diets are prescri
bed, patients should be closely monitored to assess dietary compliance
and to ensure nutritional adequacy. Evidence that the spontaneous int
ake of dietary protein decreases in patients with progressive chronic
renal failure who consume unrestricted diets should not be construed a
s an argument against the use of low-protein diets. Rather, it is a pe
rsuasive argument to restrict dietary protein intake in order to minim
ize complications of renal failure while preserving nutritional status
.